SuperGen, Inc. to Present at Bear Stearns Annual Healthcare Conference September 11th
DUBLIN, Calif., Sept. 6 /PRNewswire-FirstCall/ -- SuperGen, Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the Bear Stearns Annual Healthcare Conference on September 11, 2007, at The Grand Hyatt in New York.
SuperGen's presentation at the Bear Stearns Annual Healthcare Conference is scheduled to begin at 4 p.m. EDT. A live webcast of the presentation will be available on the investor relations section of the Company's Web site at www.supergen.com. The webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Contacts Timothy L. Enns Mary M. Vegh SuperGen, Inc. SuperGen, Inc. SVP, Corporate Communications & Manager, Investor Relations Business Development Tel: (925) 560-2845 Tel: (925) 560-0100 E-mail: mary.vegh@supergen.com E-mail: tenns@supergen.com
SuperGen, Inc.CONTACT: Timothy L. Enns, SVP, Corporate Communications & BusinessDevelopment, +1-925-560-0100, tenns@supergen.com, or Mary M. Vegh, Manager,Investor Relations, +1-925-560-2845, mary.vegh@supergen.com, both forSuperGen, Inc.
Web site: http://www.supergen.com//